| Contrast sensitivity and optical quality of the eye after instillation of timolol maleate gel-forming solution and brinzolamide ophthalmic suspension. | |
| | |
MedLine Citation:
|
PMID: 20656353 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
PURPOSE: To investigate the influence of timolol maleate 0.5% gel-forming solution and brinzolamide 1% ophthalmic suspension on contrast sensitivity, ocular higher-order aberration (HOA), and corneal surface light scattering. DESIGN: Prospective, comparative study. PARTICIPANTS: Forty normal volunteers were enrolled in this study. METHODS: We evaluated contrast sensitivity, ocular HOA, and corneal light scattering before and 2, 5, 10, and 15 minutes after instillation of antiglaucoma eyedrops. Contrast sensitivity function was assessed with the CSV-1000RN chart (Vector Vision Co., Greenville, OH). Higher-order aberration was measured for a 4-mm pupil using the Hartmann-Shack aberrometer (KR-9000PW; Topcon, Tokyo, Japan). Corneal surface light scattering was quantitatively evaluated by using the Scheimpflug camera (EAS-1000, Nidek, Aichi, Japan). MAIN OUTCOME MEASURES: Time course of changes in contrast sensitivity, ocular HOAs, and corneal light scattering. RESULTS: Both timolol gel-forming solution and brinzolamide significantly decreased contrast sensitivity for at least 5 minutes after instillation (P<0.01). There were no significant differences in contrast sensitivity between the drugs at any time points. Higher-order aberration, such as third- and fourth-order aberrations and total HOAs, significantly increased after instillation of each drug (P<0.001). Timolol gel-forming solution significantly increased HOA up to 5 minutes after instillation (P<0.05), whereas brinzolamide significantly increased HOA for at least 2 minutes after instillation (P<0.001). Corneal surface scattering significantly increased for 5 minutes after instillation of brinzolamide (P<0.01), but not after instillation of timolol gel-forming solution. CONCLUSIONS: Both drugs temporarily deteriorate contrast sensitivity function and optical quality of the eye. However, the mechanism underlying contrast sensitivity reduction seems to be different between the drugs. The reduction may be mainly attributed to increased HOA after instillation of timolol gel and increased light scattering after instillation of brinzolamide. FINANCIAL DISCLOSURE(S): The authors have no proprietary or commercial interest in any materials discussed in this article. |
| | |
Authors:
|
Takahiro Hiraoka; Masakazu Daito; Fumiki Okamoto; Takahiro Kiuchi; Tetsuro Oshika |
Related Documents
:
|
18266033 - Design process of an area-efficient photobioreactor. 19654743 - Light scattering characterization of mitochondrial aggregation in single cells. 9266093 - Effect of exposure to continuous light and melatonin on ovarian follicular kinetics in ... |
Publication Detail:
|
Type: Comparative Study; Journal Article Date: 2010-07-24 |
Journal Detail:
|
Title: Ophthalmology Volume: 117 ISSN: 1549-4713 ISO Abbreviation: Ophthalmology Publication Date: 2010 Nov |
Date Detail:
|
Created Date: 2010-10-25 Completed Date: 2010-11-03 Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 7802443 Medline TA: Ophthalmology Country: United States |
Other Details:
|
Languages: eng Pagination: 2080-7 Citation Subset: IM |
Copyright Information:
|
Copyright © 2010 American Academy of Ophthalmology. Published by Elsevier Inc. All rights reserved. |
Affiliation:
|
Department of Ophthalmology, Institute of Clinical Medicine, University of Tsukuba, Ibaraki, Japan. thiraoka@md.tsukuba.ac.jp |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Adult Antihypertensive Agents / administration & dosage* Contrast Sensitivity / drug effects* Cornea / drug effects* Female Humans Light Male Ophthalmic Solutions / administration & dosage Prospective Studies Scattering, Radiation Sulfonamides / administration & dosage* Thiazines / administration & dosage* Time Factors Timolol / administration & dosage* |
| Chemical | |
Reg. No./Substance:
|
0/Antihypertensive Agents; 0/Ophthalmic Solutions; 0/Sulfonamides; 0/Thiazines; 138890-62-7/brinzolamide; 26839-75-8/Timolol |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Laminar and prelaminar tissue displacement during intraocular pressure elevation in glaucoma patient...
Next Document: Developmental anatomy of the nasolacrimal duct: implications for congenital obstruction.